Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program.

Ja Young JeonSoo Jin LeeSieun LeeSoo Jin KimSeung Jin HanHae Jin KimDae-Jung KimYoung Seol KimJeong Taek WooKyu Jeung AhnMoonsuk NamSei Hyun BaikYongsoo ParkKwan-Woo Lee

Published in: Journal of diabetes investigation (2018)

Metformin was associated with a lower failure risk than were sulfonylureas and meglitinides, but a comparable aGI failure rate.

Keyphrases

clinical practice
quality improvement
type diabetes
cardiovascular disease
glycemic control
open label
clinical trial
skeletal muscle
insulin resistance